Is Prostate Imaging Reporting and Data System equally predictive across racial groups? A narrative review of multiparametric magnetic resonance imaging performance in Black versus White men.

BACKGROUND

Multiparametric magnetic resonance imaging (mpMRI) has become integral to prostate cancer (PCa) screening, improving detection and reducing unnecessary biopsies. This study investigated radiological disparities in mpMRI between Black and White PCa patients to improve diagnostic equity.

MATERIALS AND

METHODS

A PubMed literature search was conducted using keywords related to PCa, MRI, and racial disparities. Articles discussing mpMRI outcomes in White and Black PCa patients were selected.

RESULTS

From 13 studies, two reported higher Prostate Imaging Reporting and Data System (PI-RADS) 4 and 5 scores among Black patients, while three showed higher proportions in White patients without increased clinically significant prostate cancer (csPCa). csPCa is defined as International Society of Urological Pathology (ISUP) grade group ≥2. The csPCa detection rate in Black patients was equal to or higher than in White patients, with some studies showing more PI-RADS 3 lesions among Black patients with csPCa. Key findings include the following: (1) Development bias: PI-RADS may not account for racial variations; (2) inconsistent lesion detection across racial groups; (3) lower PI-RADS scores may mask clinically relevant cancer in Black patients; and (4) inadequate representation of the disease in Black men. Anatomical variations may affect lesion visibility, requiring dedicated imaging pathology studies.

CONCLUSIONS

While valuable for PCa detection, current mpMRI applications may contribute to racial disparities and biopsies should not be omitted in black patients with negative mpMRI or PI-RADS 3 lesions. Addressing these disparities requires inclusive research and consideration of racial variations in diagnostic pathways.